Double balloon catheter and methods for homogeneous drug delivery using the same

• US 8,603,064 B2
• Filed: 04/13/2012
• Issued: 12/10/2013
• Est. Priority Date: 09/22/2008
• Status: Active Grant

• Current Assignee: Covidien LP (Medtronic Plc)
• Original Assignee: Covidien LP (Medtronic Plc)
• Inventors: Hattangadi, Neil, Lerner, Daniel, Olivera, Ryan
• Primary Examiner(s): Mehta, Bhisma
• Application Number:
  US13/446,400
• Publication Number:
  US 20120259315A1
• Time in Patent Office: 606 Days
• Field of Search: 604/96.01, 604/100.01, 604/101.01, 604/101.03, 604/101.04, 604/101.05, 604/102.01, 604/102.02, 604/102.03, 604/103.1, 604/506, 604/507, 604/508, 604/509
• US Class Current: 604/509
• CPC Class Codes: A61L 2300/416 Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
• CPC Class Codes: A61L 2300/602 Type of release, e.g. controlled, sustained, slow
• CPC Class Codes: A61L 29/16 Biologically active materials, e.g. therapeutic substances A61L29/048 takes precedence
• CPC Class Codes: A61M 2025/1052 for temporarily occluding a vessel for isolating a sector
• CPC Class Codes: A61M 25/007 Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
• CPC Class Codes: A61M 25/1011 Multiple balloon catheters

Abstract

The present disclosure is directed to a catheter for site-specific delivery of a therapeutic agent to a blood vessel of a patient. The catheter further includes an elongated shaft having at least one inner lumen, a distal end and a proximal end and proximal and distal vessel-conforming balloons where each is separately positionable and inflatable, and when inflated, substantially restricts blood flow in the vessel and creates a treatment window of a defined but variable length for delivery of the therapeutic agent. The catheter optionally includes at least one marker band adjacent to the proximal balloon and at least one marker band adjacent to the distal balloon. At least one lateral aperture positioned in the window is in fluid communication with a drug delivery conduit located within either the inner shaft or the outer shaft to provide a homogeneous concentration of the therapeutic agent to the window.

Claims

1. A method for site-specific delivery of a therapeutic agent to a blood vessel of a patient comprising the steps of:

inflating first and second balloons of a catheter to define a treatment window between the first and second balloons;

maintaining a fluid within the treatment window;

selectively opening a closed drain passage that extends through the catheter to allow the fluid within the treatment window to be displaced from the treatment window and into the catheter through a leak aperture defined within a shaft of the catheter;

delivering a therapeutic agent to the treatment window to displace the fluid from within the treatment window; and

upon opening the drain passage, displacing the fluid through the drain passage by moving the fluid from the leak aperture to an opening defined in a distal end of the catheter that is positioned distally of the first and second balloons.

2. The method of claim 1 further comprising the step of delivering the therapeutic agent through the catheter to the treatment window.

3. The method of claim 1 wherein the step of inflating the first and second balloons includes inflating the first and second balloons to conform to an inner surface of a blood vessel to inhibit the flow of blood through the blood vessel.

4. The method of claim 1 further comprising the step of supporting at least one marker on the catheter.

5. The method of claim 4 further comprising the step of positioning the at least one marker adjacent at least one of the first and second balloons.

6. The method of claim 1 further comprising the step of changing a length of the treatment window.

7. The method of claim 6 further comprising the steps of:

supporting the first balloon on an inner shaft of the catheter;

supporting the second balloon on an outer shaft of the catheter; and

selectively moving at least one of the inner shaft and the outer shaft relative to the other shaft to change the length of the treatment window.

8. A method for site-specific delivery of a therapeutic agent to a blood vessel of a patient comprising the steps of:

inflating first and second balloons of a catheter to define a treatment window between the first and second balloons;

maintaining a fluid within the treatment window;

selectively opening a leak aperture defined within the catheter to allow the fluid within the treatment window to be displaced from the treatment window and into a drain passage that extends through the catheter;

delivering a therapeutic agent to the treatment window to displace the fluid from within the treatment window; and

positioning a guidewire within the catheter to block the leak aperture and prevent displacement of the fluid from the treatment window.

9. The method of claim 8 further comprising the step of selectively moving the guidewire to uncover the leak aperture and permit displacement of the fluid from the treatment window.

10. A method of site-specific delivery of a therapeutic agent to a blood vessel of a patient comprising:

inserting a catheter into the vessel, the catheter supporting a proximal balloon and a distal balloon and defining a plurality of apertures;

inflating the proximal balloon to substantially restrict blood flow through the vessel;

inflating the distal balloon to form a treatment window between the proximal balloon and the distal balloon;

positioning a guidewire within the catheter to block a distal leak aperture defined within the catheter;

moving the guidewire to enable fluid within the treatment window to be displaced from the treatment window through the distal leak aperture and distally through a distal end of the catheter; and

delivering the therapeutic agent through at least one of the plurality of apertures to displace the fluid disposed within the treatment window through the distal leak aperture to provide a substantially homogenous concentration of therapeutic agent within the treatment window.

11. The method of claim 10, wherein an amount of the therapeutic agent delivered to the treatment window is sufficient to substantially fill the treatment window.

12. The method of claim 10, wherein the therapeutic agent is selected from the group consisting of antiproliferative, anti-inflammatory, antineoplastic, antiplatelet, anticoagulant, antifibrin, antithrombin, antimitotic, antibiotic, and antioxidant substances.

13. The method of claim 10, wherein the therapeutic agent is paclitaxel.

14. The method of claim 10, wherein the distal balloon is inflated to form the treatment window prior to the step of delivering the therapeutic agent through the at least one of the plurality of apertures.

15. The method of claim 10 further comprising the step of supporting at least one marker on the catheter.

16. The method of claim 15 further comprising the step of positioning the at least one marker adjacent at least one of the proximal balloon and the distal balloon.

17. The method of claim 10 further comprising the step of changing a length of the treatment window.